Eurofins 9M Revenues €5.61 Bln

By Reuters News

- Eurofins Scientific SE EUFI.PA:

  • EUROFINS DELIVERS IMPROVING ORGANIC GROWTH THROUGH 9M 2026; REMAINS ON TRACK FOR 2026 AND MID-TERM PROFITABILITY OBJECTIVES

  • REPORTED REVENUES IN 9M 2026 TOTAL €5,614M, UP 3.7% VERSUS 9M 2025

  • EXPECTS 2026 REVENUES FROM ACQUISITIONS ABOVE PREVIOUS OBJECTIVE OF €250M

  • EXPECTS ADJUSTED EBITDA MARGIN IMPROVEMENT IN 2026 ABOVE FY 2025 MARGIN OF 22.5%

  • FY 2026 ORGANIC GROWTH IS LIKELY TO BE BELOW PREVIOUS MID-SINGLE-DIGIT OBJECTIVE

Further company coverage: EUFI.PA

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk